335 related articles for article (PubMed ID: 36235168)
1. Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents.
Sflakidou E; Leonidis G; Foroglou E; Siokatas C; Sarli V
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235168
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products.
Trendowski M
Drugs; 2015 Nov; 75(17):1993-2016. PubMed ID: 26501980
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs).
Gao W; Zhang J; Xiang J; Zhang L; Wu C; Dhal PK; Chen B
Curr Cancer Drug Targets; 2016; 16(6):469-79. PubMed ID: 27174056
[TBL] [Abstract][Full Text] [Related]
4. Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy.
Yaghoubi S; Karimi MH; Lotfinia M; Gharibi T; Mahi-Birjand M; Kavi E; Hosseini F; Sineh Sepehr K; Khatami M; Bagheri N; Abdollahpour-Alitappeh M
J Cell Physiol; 2020 Jan; 235(1):31-64. PubMed ID: 31215038
[TBL] [Abstract][Full Text] [Related]
5. Natural Product Based Antibody Drug Conjugates: Clinical Status as of November 9, 2020.
Newman DJ
J Nat Prod; 2021 Mar; 84(3):917-931. PubMed ID: 33635651
[TBL] [Abstract][Full Text] [Related]
6. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of PNU-159682 antibody drug conjugates (ADCs).
Holte D; Lyssikatos JP; Valdiosera AM; Swinney Z; Sisodiya V; Sandoval J; Lee C; Aujay MA; Tchelepi RB; Hamdy OM; Gu C; Lin B; Sarvaiya H; Pysz MA; Laysang A; Williams S; Jun Lee D; Holda MK; Purcell JW; Gavrilyuk J
Bioorg Med Chem Lett; 2020 Dec; 30(24):127640. PubMed ID: 33127540
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Application of Diverse Marine-derived Natural Products in Cancer Therapy.
Yun CW; Kim HJ; Lee SH
Anticancer Res; 2019 Oct; 39(10):5261-5284. PubMed ID: 31570422
[TBL] [Abstract][Full Text] [Related]
9. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics.
Gerber HP; Koehn FE; Abraham RT
Nat Prod Rep; 2013 May; 30(5):625-39. PubMed ID: 23525375
[TBL] [Abstract][Full Text] [Related]
10. Natural products and their analogues as efficient anticancer drugs.
Coseri S
Mini Rev Med Chem; 2009 May; 9(5):560-71. PubMed ID: 19456286
[TBL] [Abstract][Full Text] [Related]
11. Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids.
Hamilton GS
Biologicals; 2015 Sep; 43(5):318-32. PubMed ID: 26115630
[TBL] [Abstract][Full Text] [Related]
12. Advances in targeted therapy for pancreatic cancer.
Xing L; Lv L; Ren J; Yu H; Zhao X; Kong X; Xiang H; Tao X; Dong D
Biomed Pharmacother; 2023 Dec; 168():115717. PubMed ID: 37862965
[TBL] [Abstract][Full Text] [Related]
13. Natural Health Products (NHP's) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends.
Scaria B; Sood S; Raad C; Khanafer J; Jayachandiran R; Pupulin A; Grewal S; Okoko M; Arora M; Miles L; Pandey S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187200
[TBL] [Abstract][Full Text] [Related]
14. Metal Complexes of Natural Product Like-compounds with Antitumor Activity.
Heras BL; Amesty Á; Estévez-Braun A; Hortelano S
Anticancer Agents Med Chem; 2019; 19(1):48-65. PubMed ID: 29692264
[TBL] [Abstract][Full Text] [Related]
15. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
Song F; Huo X; Guo Z
Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
[TBL] [Abstract][Full Text] [Related]
16. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
Decker M
Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
[TBL] [Abstract][Full Text] [Related]
17. Natural products from aquatic eukaryotic microorganisms for cancer therapy: Perspectives on anti-tumour properties of ciliate bioactive molecules.
Catalani E; Proietti Serafini F; Zecchini S; Picchietti S; Fausto AM; Marcantoni E; Buonanno F; Ortenzi C; Perrotta C; Cervia D
Pharmacol Res; 2016 Nov; 113(Pt A):409-420. PubMed ID: 27650755
[TBL] [Abstract][Full Text] [Related]
18. Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions.
Ferraro E; Drago JZ; Modi S
Breast Cancer Res; 2021 Aug; 23(1):84. PubMed ID: 34380530
[TBL] [Abstract][Full Text] [Related]
19. Natural products: An upcoming therapeutic approach to cancer.
Dutta S; Mahalanobish S; Saha S; Ghosh S; Sil PC
Food Chem Toxicol; 2019 Jun; 128():240-255. PubMed ID: 30991130
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.
Hashem S; Ali TA; Akhtar S; Nisar S; Sageena G; Ali S; Al-Mannai S; Therachiyil L; Mir R; Elfaki I; Mir MM; Jamal F; Masoodi T; Uddin S; Singh M; Haris M; Macha M; Bhat AA
Biomed Pharmacother; 2022 Jun; 150():113054. PubMed ID: 35658225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
